Effect of bone marrow derived mesenchymal stem cell conditioned media for neurite outgrowth in human ntera-2 neurons

Jin Soo Oh, Meng Lu Liu, Hong Lian Jin, Sung Su An, Keung Nyun Kim, Do Heum Yoon, Yoon Ha

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Bone marrow derived mesenchymal stem cell(BMSC) based cell therapy can promote functional recovery and regeneration in central nervous system(CNS) disease models. These beneficial effects have been primarily attributed to the differentiation potential into varieties of cell lineages and the therapeutic paracrine factors secreted by BMSC after transplantation. Many secreted factors from BMSC have been identified recently in the conditioned media. However, the effects of these factors on the neuronal regeneration need further verification with relevant neuronal models. Ntera-2 neurons have been used for the therapy of several different CNS diseases in animal models. Recently some clinical trials have confirmed the safety and potential efficacy of Ntera-2 neurons for stroke therapy. In this study, the Ntera-2 neuron model was used to directly verify the effect of BMSC conditioned media(BMSCCM) on neurite outgrowth in vitro. Our study confirmed that the BMSC-CM could increase both the neurite length and branch number of Ntera-2 neurons, compared to the control group with non-conditioning media. Since the BMSC can secret many therapeutic factors into the conditioned media, our data support the theory that BMSC promote neurite outgrowth through secreting paracrine factors.

Original languageEnglish (US)
Pages (from-to)562-567
Number of pages6
JournalTissue Engineering and Regenerative Medicine
Volume6
Issue number4-11
StatePublished - Jun 1 2009

Fingerprint

Conditioned Culture Medium
Stem cells
Mesenchymal Stromal Cells
Neurons
Bone
Bone Marrow
Central Nervous System Diseases
Neurology
Regeneration
Mesenchymal Stem Cell Transplantation
Cell Lineage
Neurites
Therapeutics
Cell- and Tissue-Based Therapy
Neuronal Outgrowth
Animals
Animal Models
Stroke
Clinical Trials
Safety

Keywords

  • Mesenchymal stem cell-conditioned media(MSC-CM)
  • Neurite outgrowth
  • Ntera-2 neuron

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biomedical Engineering

Cite this

Oh, J. S., Liu, M. L., Jin, H. L., An, S. S., Kim, K. N., Yoon, D. H., & Ha, Y. (2009). Effect of bone marrow derived mesenchymal stem cell conditioned media for neurite outgrowth in human ntera-2 neurons. Tissue Engineering and Regenerative Medicine, 6(4-11), 562-567.

Effect of bone marrow derived mesenchymal stem cell conditioned media for neurite outgrowth in human ntera-2 neurons. / Oh, Jin Soo; Liu, Meng Lu; Jin, Hong Lian; An, Sung Su; Kim, Keung Nyun; Yoon, Do Heum; Ha, Yoon.

In: Tissue Engineering and Regenerative Medicine, Vol. 6, No. 4-11, 01.06.2009, p. 562-567.

Research output: Contribution to journalArticle

Oh, Jin Soo ; Liu, Meng Lu ; Jin, Hong Lian ; An, Sung Su ; Kim, Keung Nyun ; Yoon, Do Heum ; Ha, Yoon. / Effect of bone marrow derived mesenchymal stem cell conditioned media for neurite outgrowth in human ntera-2 neurons. In: Tissue Engineering and Regenerative Medicine. 2009 ; Vol. 6, No. 4-11. pp. 562-567.
@article{ad26d853911e4542ace4c9e252912edc,
title = "Effect of bone marrow derived mesenchymal stem cell conditioned media for neurite outgrowth in human ntera-2 neurons",
abstract = "Bone marrow derived mesenchymal stem cell(BMSC) based cell therapy can promote functional recovery and regeneration in central nervous system(CNS) disease models. These beneficial effects have been primarily attributed to the differentiation potential into varieties of cell lineages and the therapeutic paracrine factors secreted by BMSC after transplantation. Many secreted factors from BMSC have been identified recently in the conditioned media. However, the effects of these factors on the neuronal regeneration need further verification with relevant neuronal models. Ntera-2 neurons have been used for the therapy of several different CNS diseases in animal models. Recently some clinical trials have confirmed the safety and potential efficacy of Ntera-2 neurons for stroke therapy. In this study, the Ntera-2 neuron model was used to directly verify the effect of BMSC conditioned media(BMSCCM) on neurite outgrowth in vitro. Our study confirmed that the BMSC-CM could increase both the neurite length and branch number of Ntera-2 neurons, compared to the control group with non-conditioning media. Since the BMSC can secret many therapeutic factors into the conditioned media, our data support the theory that BMSC promote neurite outgrowth through secreting paracrine factors.",
keywords = "Mesenchymal stem cell-conditioned media(MSC-CM), Neurite outgrowth, Ntera-2 neuron",
author = "Oh, {Jin Soo} and Liu, {Meng Lu} and Jin, {Hong Lian} and An, {Sung Su} and Kim, {Keung Nyun} and Yoon, {Do Heum} and Yoon Ha",
year = "2009",
month = "6",
day = "1",
language = "English (US)",
volume = "6",
pages = "562--567",
journal = "Tissue Engineering and Regenerative Medicine",
issn = "1738-2696",
publisher = "Springer Science + Business Media",
number = "4-11",

}

TY - JOUR

T1 - Effect of bone marrow derived mesenchymal stem cell conditioned media for neurite outgrowth in human ntera-2 neurons

AU - Oh, Jin Soo

AU - Liu, Meng Lu

AU - Jin, Hong Lian

AU - An, Sung Su

AU - Kim, Keung Nyun

AU - Yoon, Do Heum

AU - Ha, Yoon

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Bone marrow derived mesenchymal stem cell(BMSC) based cell therapy can promote functional recovery and regeneration in central nervous system(CNS) disease models. These beneficial effects have been primarily attributed to the differentiation potential into varieties of cell lineages and the therapeutic paracrine factors secreted by BMSC after transplantation. Many secreted factors from BMSC have been identified recently in the conditioned media. However, the effects of these factors on the neuronal regeneration need further verification with relevant neuronal models. Ntera-2 neurons have been used for the therapy of several different CNS diseases in animal models. Recently some clinical trials have confirmed the safety and potential efficacy of Ntera-2 neurons for stroke therapy. In this study, the Ntera-2 neuron model was used to directly verify the effect of BMSC conditioned media(BMSCCM) on neurite outgrowth in vitro. Our study confirmed that the BMSC-CM could increase both the neurite length and branch number of Ntera-2 neurons, compared to the control group with non-conditioning media. Since the BMSC can secret many therapeutic factors into the conditioned media, our data support the theory that BMSC promote neurite outgrowth through secreting paracrine factors.

AB - Bone marrow derived mesenchymal stem cell(BMSC) based cell therapy can promote functional recovery and regeneration in central nervous system(CNS) disease models. These beneficial effects have been primarily attributed to the differentiation potential into varieties of cell lineages and the therapeutic paracrine factors secreted by BMSC after transplantation. Many secreted factors from BMSC have been identified recently in the conditioned media. However, the effects of these factors on the neuronal regeneration need further verification with relevant neuronal models. Ntera-2 neurons have been used for the therapy of several different CNS diseases in animal models. Recently some clinical trials have confirmed the safety and potential efficacy of Ntera-2 neurons for stroke therapy. In this study, the Ntera-2 neuron model was used to directly verify the effect of BMSC conditioned media(BMSCCM) on neurite outgrowth in vitro. Our study confirmed that the BMSC-CM could increase both the neurite length and branch number of Ntera-2 neurons, compared to the control group with non-conditioning media. Since the BMSC can secret many therapeutic factors into the conditioned media, our data support the theory that BMSC promote neurite outgrowth through secreting paracrine factors.

KW - Mesenchymal stem cell-conditioned media(MSC-CM)

KW - Neurite outgrowth

KW - Ntera-2 neuron

UR - http://www.scopus.com/inward/record.url?scp=84884568411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884568411&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84884568411

VL - 6

SP - 562

EP - 567

JO - Tissue Engineering and Regenerative Medicine

JF - Tissue Engineering and Regenerative Medicine

SN - 1738-2696

IS - 4-11

ER -